Univest
Univest
  • Markets

Pfizer Ltd. (PFIZER) Share Price hits fresh 52-week low as stock trades lower

  • September 9, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Pfizer Ltd. Share Price
Pfizer Ltd. (PFIZER) share price fell to a fresh 52-week low of Rs 3,792.5 today and later stood at Rs 3,795.05, down 0.54% from the previous close. Market cap was Rs 17,649.25 crore.

Pfizer Ltd. Share Price is under attention after the stock touched a fresh 52-week low of Rs 3,792.50 and was last traded at Rs 3,795.05, down 0.54% from the previous close of Rs 3,815.80. The company’s market capitalisation stood at Rs 17,649.25 cr, placing today’s move in the context of a large listed Healthcare name from the Pharmaceuticals & Drugs industry. Univest figures confirm the price action, but they do not point to a specific company trigger. The Pfizer Ltd. Share Price move is relevant because it keeps the stock in the 52-week low set while the broader valuation and sector numbers remain visible for investors tracking Pfizer Ltd. Stock News and Pfizer Ltd. Share Price Today. As of 08 October 2026 at 10:52 AM IST, the stock is trading below the day’s open and near the day low, which makes the price action worth monitoring alongside the latest fundamentals on Univest.

Table of Contents

Toggle
  • Pfizer Ltd. Share Price Today: Price Action Analysis
  • Pfizer Ltd. (PFIZER) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Pfizer Ltd.
  • About Pfizer Ltd.
  • Track Pfizer Ltd. Share Price on Univest
  • Frequently Asked Questions
    • What happened to Pfizer Ltd. Share Price today?
    • Why did Pfizer Ltd. Share Price hit a fresh 52-week low?
    • What is Pfizer Ltd. Share Price today?
    • What is the market cap of Pfizer Ltd. Share Price?
    • What do Pfizer Ltd. valuation ratios show?
    • How do Pfizer Ltd. ROE and ROCE compare in the sector?
    • What does the latest revenue number for Pfizer Ltd. mean?
    • How does Pfizer Ltd. compare with listed peers?
    • Where can investors track Pfizer Ltd. Share Price news?

Pfizer Ltd. Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 3,795.05
Previous Close Rs 3,815.8
Today's Move Rs -20.75 (-0.54%)
Open Rs 3,824.95
High Rs 3,824.95
Low Rs 3,792.5
Market Capitalisation Rs 17,649.25 crore

Pfizer Ltd. (PFIZER) traded at Rs 3,795.05 versus the previous close of Rs 3,815.8, a fall of 0.54%. The stock opened at Rs 3,824.95, reached a high of Rs 3,824.95, touched a low of Rs 3,792.5.

Pfizer Ltd. Share Price moved from a previous close of Rs 3,815.80 to Rs 3,795.05, a decline of Rs 20.75 or 0.54%. The stock opened at Rs 3,824.95, matched the day’s high at Rs 3,824.95 and touched a low of Rs 3,792.50, which is also the fresh 52-week low. In that range, Pfizer Ltd. Share Price stayed close to the lower end through the latest trade, while market capitalisation remained at Rs 17,649.25 cr. This is the key price fact pattern for Pfizer Ltd. Share Price today: a fresh yearly low, a modest intraday fall and a trading band that stayed tight. According to latest Univest figures, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Pfizer Ltd. Share Price Live, the next section places this move against the company’s financial context on Univest.

Pfizer Ltd. (PFIZER) Fundamental Analysis

Metric Value
Market Capitalisation Rs 17,649.25 crore
P/E Ratio 23.75x
P/B Ratio 3.96x
ROE 17.16%
ROCE 23.39%
EPS Rs 160.7
Book Value Per Share Rs 963.41
Dividend Yield 1.97%

Pfizer Ltd. (PFIZER) fundamental metrics show P/E 23.75x, P/B 3.96x, ROE 17.16%, ROCE 23.39%. Taken on their own, these numbers offer context rather than a trading signal.

Pfizer Ltd. has a market capitalisation of Rs 17,649.25 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.75x, P/B at 3.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.16% and ROCE of 23.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 160.7, book value per share of Rs 963.41, dividend yield of 1.97%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.9x, median ROE of 11.53%, median ROCE of 13.32%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 23.75x
Benchmark Median P/E 31.9x
Benchmark Average P/E 48.62x
Benchmark P/E Range 3.58x to 708.87x
Company P/B Ratio 3.96x
Benchmark Median P/B 2.96x
Company ROE 17.16%
Benchmark Median ROE 11.53%
Company ROCE 23.39%
Benchmark Median ROCE 13.32%
Company Market Capitalisation Rs 17,649.25 crore
Benchmark Median Market Cap Rs 828.13 crore

Pfizer Ltd. (PFIZER) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Pfizer Ltd. (PFIZER) has a P/E ratio of 23.75x, which is below the benchmark median of 31.9x, a difference of -25.55%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Pfizer Ltd. (PFIZER) has a ROE of 17.16%, which is above the benchmark median of 11.53%, a difference of +48.83%. Pfizer Ltd. (PFIZER) has a ROCE of 23.39%, which is above the benchmark median of 13.32%, a difference of +75.6%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Suven Pharmaceuticals Ltd. COHANCE 17,486.61 163.93 4.52 4.02 6.12
Glenmark Life Sciences Ltd. ALIVUS 16,823.37 27.9 4.83 18.41 24.61
Eris Lifesciences Ltd. ERIS 16,477.29 24.71 3.95 19.23 14.47
Alembic Pharmaceuticals Ltd. APLLTD 16,391.4 23.61 2.8 12.35 11.74
Natco Pharma Ltd. NATCOPHARM 16,158.35 13.89 1.7 16.3 17.16

Pfizer Ltd. (PFIZER) has a P/E ratio of 23.75x compared with the displayed peer median of 24.71x. The comparison is relative and should not be read as a recommendation. Its ROE of 17.16% compares with a peer median of 16.3% across the companies shown in the table. ROCE stood at 23.39% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 17,649.25 crore. It is larger by market capitalisation than all 5 peers shown.

Why Investors Are Watching Pfizer Ltd.

  • Pfizer Ltd. Share Price touched a fresh 52-week low of Rs 3,792.50 and is last traded at Rs 3,795.05.
  • The day’s move was Rs 20.75 lower, or 0.54%, versus the previous close of Rs 3,815.80.
  • Pfizer Ltd. Fundamental Analysis shows P/E of 23.75, P/B of 3.96, ROE of 17.16% and ROCE of 23.39%.
  • Pfizer Ltd. Market Cap stood at Rs 17,649.25 cr, keeping the stock in a significant Healthcare name category.
  • Peer Comparison shows the stock’s valuation and return metrics sit differently from several same-industry listed peers.

About Pfizer Ltd.

Pfizer Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of the listed Indian pharmaceutical universe tracked on Pfizer Ltd. NSE and Pfizer Ltd. BSE, and its business profile is best read through Pfizer Ltd. Company News, Pfizer Ltd. Financial Results and Pfizer Ltd. Stock Performance. The June 2026 revenue figure of Rs 653.17 cr shows the scale of the business in the latest reported quarter. For investors looking at Pfizer Ltd. Share Price, the core company context is its place in a regulated healthcare market where earnings, returns on capital and valuation ratios are central to analysis. Univest presents the stock alongside sector and peer context so the price move can be read with the broader company overview in mind. Pfizer Ltd. Share Price therefore sits at the intersection of market update, financial analysis and industry comparison on Univest.

Track Pfizer Ltd. Share Price on Univest

Use Pfizer Ltd. (PFIZER) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

You can track Pfizer Ltd. Share Price on Univest for live price updates, key ratios, 52-week levels, market cap, company overview and sector context. Univest also brings together Pfizer Ltd. Stock News, Pfizer Ltd. Latest News and Pfizer Ltd. Earnings-related updates in one place. For readers following Pfizer Ltd. Share Price Today, that makes it easier to review the stock’s movement, valuation and peer positioning without jumping between separate screens. Univest keeps the focus on verified figures and clear market context for Pfizer Ltd. Share Price.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What happened to Pfizer Ltd. Share Price today?

Ans. Pfizer Ltd. Share Price fell 0.54% to Rs 3,795.05 and touched a fresh 52-week low of Rs 3,792.50. The stock opened at Rs 3,824.95 and traded below the previous close of Rs 3,815.80.

Why did Pfizer Ltd. Share Price hit a fresh 52-week low?

Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. Pfizer Ltd. Share Price touched Rs 3,792.50 during the day, which makes the yearly low visible in the trading range.

What is Pfizer Ltd. Share Price today?

Ans. Pfizer Ltd. Share Price was last traded at Rs 3,795.05. It was lower than the previous close of Rs 3,815.80 and remained close to the day’s low of Rs 3,792.50.

What is the market cap of Pfizer Ltd. Share Price?

Ans. Pfizer Ltd. Market Cap stood at Rs 17,649.25 cr. That places Pfizer Ltd. Share Price among the larger names in the Healthcare sector and well above the industry benchmark median market cap.

What do Pfizer Ltd. valuation ratios show?

Ans. Pfizer Ltd. Share Price trades at a P/E of 23.75 and a P/B of 3.96. Those figures sit below the same-industry median P/E and above the median P/B, so the valuation picture is mixed.

How do Pfizer Ltd. ROE and ROCE compare in the sector?

Ans. Pfizer Ltd. Share Price is backed by ROE of 17.16% and ROCE of 23.39%. Both sit above the same-industry medians, which gives the stock stronger return metrics than many peers in the benchmark set.

What does the latest revenue number for Pfizer Ltd. mean?

Ans. The latest quarterly revenue was Rs 653.17 cr for Jun 2026. For Pfizer Ltd. Share Price, that figure adds operating context to the valuation and return ratios, but it should be read with the full financial picture.

How does Pfizer Ltd. compare with listed peers?

Ans. Pfizer Ltd. Share Price has a market cap above several peers in the five-company comparison, while its P/E is far below Suven Pharmaceuticals Ltd. and close to Eris Lifesciences Ltd. and Alembic Pharmaceuticals Ltd.

Where can investors track Pfizer Ltd. Share Price news?

Ans. Investors can track Pfizer Ltd. Share Price news on Univest, where live price, 52-week levels, market cap, valuation ratios and peer context are presented together. That keeps Pfizer Ltd. Stock News in one view.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply